Insulin-like Growth Factor-1 Receptor and ErbB Kinase Inhibitor Combinations Block Proliferation and Induce Apoptosis through Cyclin D1 Reduction and Bax Activation

Por Wilsbacher, Julie L., Zhang, Qian, Tucker, Lora A., Hubbard, Robert D., Sheppard, George S., Bamaung, Nwe Y., Fidanze, Steve D., Wang, Gary T., Hu, Xiaoming, Davidsen, Steven K., Bell, Randy L., Wang, Jieyi
Publicado em 2008

Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor

Por Wang, Jieyi, Tucker, Lora A., Stavropoulos, Jason, Zhang, Qian, Wang, Yi-Chun, Bukofzer, Gail, Niquette, Amanda, Meulbroek, Jonathan A., Barnes, David M., Shen, Jianwei, Bouska, Jennifer, Donawho, Cherrie, Sheppard, George S., Bell, Randy L.
Publicado em 2008

Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605

Por Buchanan Fritz G, Donawho Cherrie, Sheppard George S, Johnson Eric F, Soni Niru B, Grudzien Meagan M, Zhang Qian, Hubbard Robert D, Wang Yi-Chun, Meulbroek Jonathan A, Jung Paul M, Pappano William N, Davidsen Steven K, Bell Randy L, Wang Jieyi
Publicado em 2009-09-01

Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605

Por Pappano, William N, Jung, Paul M, Meulbroek, Jonathan A, Wang, Yi-Chun, Hubbard, Robert D, Zhang, Qian, Grudzien, Meagan M, Soni, Niru B, Johnson, Eric F, Sheppard, George S, Donawho, Cherrie, Buchanan, Fritz G, Davidsen, Steven K, Bell, Randy L, Wang, Jieyi
Publicado em 2009